Pilot Trial of Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy
Phase of Trial: Phase 0
Latest Information Update: 10 Feb 2018
At a glance
- Drugs Atezolizumab (Primary) ; Radium 223 chloride (Primary)
- Indications Bone metastases; Urogenital cancer
- Focus Therapeutic Use
- 10 Feb 2018 Trial design presented at the 2018 Genitourinary Cancers Symposium
- 03 Nov 2017 Status changed from not yet recruiting to recruiting.
- 06 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.